Abbott Laboratories (ABT)
105.90
-0.02
(-0.02%)
USD |
NYSE |
May 03, 16:00
105.84
-0.06
(-0.06%)
After-Hours: 20:00
Abbott Laboratories Cash from Financing (TTM): -7.091B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.091B |
| September 30, 2023 | -6.496B |
| June 30, 2023 | -5.699B |
| March 31, 2023 | -5.223B |
| December 31, 2022 | -7.636B |
| September 30, 2022 | -8.065B |
| June 30, 2022 | -7.899B |
| March 31, 2022 | -8.35B |
| December 31, 2021 | -5.494B |
| September 30, 2021 | -4.395B |
| June 30, 2021 | -4.933B |
| March 31, 2021 | -3.011B |
| December 31, 2020 | -2.779B |
| September 30, 2020 | -4.177B |
| June 30, 2020 | -2.775B |
| March 31, 2020 | -3.882B |
| December 31, 2019 | -4.289B |
| September 30, 2019 | -6.88B |
| June 30, 2019 | -3.896B |
| March 31, 2019 | -5.078B |
| December 31, 2018 | -10.39B |
| September 30, 2018 | -5.727B |
| June 30, 2018 | -8.584B |
| March 31, 2018 | -7.337B |
| December 31, 2017 | -5.281B |
| Date | Value |
|---|---|
| September 30, 2017 | 8.335B |
| June 30, 2017 | 7.975B |
| March 31, 2017 | 8.18B |
| December 31, 2016 | 11.15B |
| September 30, 2016 | -2.854B |
| June 30, 2016 | -2.923B |
| March 31, 2016 | -3.118B |
| December 31, 2015 | -2.236B |
| September 30, 2015 | -2.439B |
| June 30, 2015 | -1.895B |
| March 31, 2015 | -2.14B |
| December 31, 2014 | -2.742B |
| September 30, 2014 | -3.911B |
| June 30, 2014 | -4.199B |
| March 31, 2014 | -3.115B |
| December 31, 2013 | -6.696B |
| September 30, 2013 | -2.322B |
| June 30, 2013 | -4.354B |
| March 31, 2013 | -4.703B |
| December 31, 2012 | 195.00M |
| September 30, 2012 | -3.995B |
| June 30, 2012 | -4.072B |
| March 31, 2012 | -5.573B |
| December 31, 2011 | -6.423B |
| September 30, 2011 | -4.832B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-8.35B
Minimum
Mar 2022
-2.775B
Maximum
Jun 2020
-5.419B
Average
-5.223B
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
| Stryker Corp | -1.531B |
| Boston Scientific Corp | 1.643B |
| Insulet Corp | -13.60M |
| Intuitive Surgical Inc | 46.90M |
| Edwards Lifesciences Corp | -442.70M |